Zemplar and coronary artery disease Patient Reports February 10, 2012

Zemplar Side Effects Report #5993906-3
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Dec 03, 2008. Male patient, 52 years of age, was diagnosed with nephrosclerosis, coronary artery disease  and was treated with Zemplar. After drug was administered, patient experienced the following side effects: coronary artery disease , treatment noncompliance. Zemplar dosage: unknown. During the same period patient was treated with PARENTROVITE, ACETYLSALICYLIC ACID SRT, CYANOCOBALAMIN, FOLIC ACID, CALCIUM CARBONATE, CINACALCET, POLYSTYRENE SULFONATE, LANTHANUM CARBONATE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #6020289-5
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Dec 19, 2008. Male patient, 52 years of age, was diagnosed with nephrosclerosis, coronary artery disease  and was treated with Zemplar. After drug was administered, patient experienced the following side effects: coronary artery disease , treatment noncompliance. Zemplar dosage: unknown. During the same period patient was treated with ORALOVITE, TROMBYL, BETOLVIDON, FOLACIN, CALCITUGG, MIMPARA, POLYSTYRENE SULFONATE, FOSRENOL. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #6045803-5
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Jan 15, 2009. Male patient, 73 years of age, weighting 171.5 lb, was diagnosed with hyperparathyroidism secondary, anaemia, vitamin supplementation, atrial fibrillation , coronary artery disease , hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: chest pain , coronary artery disease . Zemplar dosage: unknown. During the same period patient was treated with ARANESP, NEUROBION, SUPERAMINE, VENOFER, ANGORON, DILATREND, MONOSORDIL, RENAGEL. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5016527-8
Zemplar side effect was reported by a Physician from GERMANY on May 22, 2006. Female patient, 66 years of age, weighting 169.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: angina pectoris, coronary artery disease . Zemplar dosage: unknown. During the same period patient was treated with ALUMINIUM CHLORHYDROXIDE, DECOSTRIOL, VIGANTEOLETTEN, VITARENAL, POLYSTYRENE SULFONATE, ACETYLSALICYLIC ACID SRT, DELIX PROTECT. Patient was hospitalized. Patient recovered.


Zemplar Side Effects Report #5556030-X
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 04, 2007. Male patient, 62 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary, coronary artery disease , mineral supplementation, nutritional support , anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood pressure decreased, chest pain , coronary artery disease , ventricular tachycardia. Zemplar dosage: unknown. During the same period patient was treated with ISOSORBIDE MONONITRATE, CALCIUM CARBONATE, INTELLECTA AMP, SEVELAMER, EPOETIN BETA, TICLOPIDINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5566407-4
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 04, 2007. Male patient, 62 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary, coronary artery disease , mineral supplementation, nutritional support , anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood pressure decreased, chest pain , coronary artery disease , ventricular tachycardia. Zemplar dosage: unknown. During the same period patient was treated with ISOSORBIDE MONONITRATE, CALCIUM CARBONATE, INTELLECTA AMP, SEVELAMER, EPOETIN BETA, TICLOPIDINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5261143-6
Zemplar side effect was reported by a Physician from GERMANY on Feb 28, 2007. Male patient, weighting 162.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute coronary syndrome, angina pectoris, cardiac disorder, coronary artery disease , coronary artery occlusion, myocardial infarction. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 01/21/2007.

Zemplar Side Effects Report #5285137-X
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Mar 26, 2007. Female patient, weighting 99.21 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, angina pectoris, coronary artery disease , dyspnoea, full blood count decreased, left ventricular failure, occult blood positive, renal failure chronic, supraventricular tachycardia. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDTE, ASASANTIN, OMEPRAZOLE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5288824-2
Zemplar side effect was reported by a Physician from GERMANY on Mar 27, 2007. Male patient, weighting 162.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute coronary syndrome, angina pectoris, cardiac disorder, coronary artery disease , coronary artery occlusion, myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, CPS PULVER, DARBEPOETIN ALFA, PRAVASTATIN STADA, IRBESARTAN, DIGITOXIN, MOLSIDOMINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 01/21/2007.


Zemplar Side Effects Report #5301580-4
Zemplar side effect was reported by a Physician from GERMANY on Apr 10, 2007. Male patient, weighting 162.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute coronary syndrome, angina pectoris, cardiac disorder, coronary artery disease , coronary artery occlusion, myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, CPS PULVER, DARBEPOETIN ALFA, PRAVASTATIN STADA, IRBESARTAN, DIGITOXIN, MOLSIDOMINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 01/21/2007.

Zemplar Side Effects Report #5303778-8
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Apr 11, 2007. Female patient, weighting 99.21 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, angina pectoris, coronary artery disease , dyspnoea, full blood count decreased, left ventricular failure, occult blood positive, renal failure chronic, supraventricular tachycardia. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDTE, ASASANTIN, OMEPRAZOLE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5321880-1
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Apr 30, 2007. Female patient, weighting 99.21 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, angina pectoris, coronary artery disease , dyspnoea, full blood count decreased, left ventricular failure, occult blood positive, supraventricular tachycardia. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDTE, ASASANTIN, OMEPRAZOLE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5328005-7
Zemplar side effect was reported by a Physician from GERMANY on May 07, 2007. Female patient, weighting 121.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: coronary artery disease , duodenal ulcer, gastrointestinal haemorrhage, peripheral arterial occlusive disease, wound dehiscence. Zemplar dosage: unknown. During the same period patient was treated with GASTAL, CALCIUM CARBONATE, THEOPHYLLINE, SPIRIVA, FRAGMIN PTE, EPOGEN. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5359676-7
Zemplar side effect was reported by a Physician from GERMANY on June 05, 2007. Female patient, weighting 121.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: coronary artery disease , duodenal ulcer, gastrointestinal haemorrhage, peripheral arterial occlusive disease, wound dehiscence. Zemplar dosage: unknown. During the same period patient was treated with GASTAL, CALCIUM CARBONATE, THEOPHYLLINE, SPIRIVA, FRAGMIN PTE, EPOGEN. Patient was hospitalized. Patient recovered.


Zemplar Side Effects Report #5518785-X
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Nov 05, 2007. Male patient, weighting 130.1 lb, was diagnosed with hyperparathyroidism secondary, anaemia, iron deficiency anaemia, hyperuricaemia, hypertension, mineral supplementation, vitamin supplementation and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, acute pulmonary oedema, coronary artery disease , sinus tachycardia. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN, FILICIN, ALLOPURINOL, QUINAPRIL, AMLODIPINE, CALCIUM CARBONATE, NEUROBION. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5700344-7
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Mar 31, 2008. Male patient, weighting 143.3 lb, was diagnosed with hyperparathyroidism secondary, iron deficiency and was treated with Zemplar. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, coronary artery disease , diabetic gangrene, hypertension, myocardial infarction, peripheral arterial occlusive disease, sepsis , type 2 diabetes mellitus. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, PENTAERITHRITYL TETRANITRATE, RAMIPRIL, SIMVASTATIN, THIAMAZOLE, EPOETIN BETA, FERRLECIT. Patient died on 07/23/2007.

Zemplar Side Effects Report #5800107-8
Zemplar side effect was reported by a Physician from GERMANY on June 26, 2008. Male patient, weighting 162.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute coronary syndrome, acute myocardial infarction, angina pectoris, cardiac disorder, coronary artery disease , coronary artery occlusion. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, CPS PULVER, DARBEPOETIN ALFA, PRAVASTATIN STADA, IRBESARTAN, DIGITOXIN, MOLSIDOMINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 01/21/2007.

Zemplar Side Effects Report #4826374-5
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 06, 2005. Male patient, weighting 185.2 lb, was diagnosed with hyperparathyroidism secondary, nephrogenic anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: aortic valve stenosis, coronary artery disease , delirium, dysphagia, pneumonia . Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA. Patient was hospitalized and became disabled. Patient died on 10/15/2005.

Zemplar Side Effects Report #4894516-1
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 06, 2005. Male patient, weighting 185.2 lb, was diagnosed with hyperparathyroidism secondary, nephrogenic anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: aortic valve stenosis, atelectasis, candidiasis, cardiac arrest , cerebral atrophy, cerebral ischaemia, coronary artery disease , coronary artery stenosis, delirium. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA. Patient was hospitalized and became disabled. Patient died on 10/15/2005.


Zemplar Side Effects Report #5040523-8
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 06, 2005. Male patient, weighting 185.2 lb, was diagnosed with hyperparathyroidism secondary, nephrogenic anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: aortic stenosis, cardiac arrest , coronary artery disease , delirium, depression , dysphagia, lobar pneumonia, pneumonia aspiration. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA. Patient was hospitalized and became disabled. Patient died on 10/15/2005.

Zemplar Side Effects Report #5838774-5
Zemplar side effect was reported by a Physician from AUSTRIA on July 29, 2008. Female patient, 84 years of age, weighting 178.6 lb, was diagnosed with hyperparathyroidism, atrial fibrillation  and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, coronary artery disease , pyrexia, skin ulcer. Zemplar dosage: unknown. During the same period patient was treated with AMIODARONE. Patient died on 12/07/2005.

Zemplar Side Effects Report #6047516-2
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 19, 2009. Male patient, weighting 160.1 lb, was diagnosed with hyperparathyroidism, cardiac disorder, cardiac failure congestive, prostatomegaly, blood potassium decreased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: ascites, cardiac arrest , cardiac failure congestive, coronary artery disease , pericardial effusion, renal failure, respiratory failure. Zemplar dosage: unknown. During the same period patient was treated with ASPIRIN, CARVEDILOL, LASIX, METOPROLOL TARTRATE, NEPHROVITE, AVODART, UROXATAL. Patient died on 01/02/2009.

Zemplar Side Effects Report #6050406-2
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 19, 2009. Male patient, weighting 160.1 lb, was diagnosed with hyperparathyroidism, cardiac disorder, cardiac failure congestive, prostatomegaly, blood potassium decreased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: ascites, cardiac arrest , cardiac failure congestive, coronary artery disease , pleural effusion, renal failure, respiratory failure. Zemplar dosage: unknown. During the same period patient was treated with ASPIRIN, CARVEDILOL, LASIX, METOPROLOL TARTRATE, NEPHROVITE, AVODART, UROXATAL. Patient died on 01/02/2009.